Literature DB >> 1984695

Axis II comorbidity in substance abusers.

E P Nace1, C W Davis, J P Gaspari.   

Abstract

OBJECTIVE: To assess the complex relationship between substance abuse and personality disorders, the authors determined the prevalence of personality disorders in a group of middle-class substance abusers and compared the subjects who had personality disorders with those who did not.
METHOD: The subjects were drawn from patients consecutively admitted to an inpatient substance abuse program in a private psychiatric hospital; they were the first 100 who agreed to participate. Substance dependence was diagnosed according to DSM-III-R, and the patients were assessed with the Structured Clinical Interview for DSM-III-R Personality Disorders, Alcohol Use Inventory, MMPI, Health and Daily Living Form, Shipley Institute of Living Scale, and measures of chemical use and life satisfaction.
RESULTS: Of the 100 substance abusers, 57 had personality disorders. These patients differed significantly from the 43 patients without personality disorders in several ways: they had greater involvement with illegal drugs, had different patterns of alcohol use, had greater psychopathology, were less satisfied with their lives, and were more impulsive, isolated, and depressed.
CONCLUSIONS: Because of the marked differences between the substance abusers with and without personality disorders, a uniform approach to substance abuse treatment may be inadequate.

Entities:  

Mesh:

Year:  1991        PMID: 1984695     DOI: 10.1176/ajp.148.1.118

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

1.  Personality disorders in early adolescence and the development of later substance use disorders in the general population.

Authors:  Patricia Cohen; Henian Chen; Thomas N Crawford; Judith S Brook; Kathy Gordon
Journal:  Drug Alcohol Depend       Date:  2007-01-16       Impact factor: 4.492

Review 2.  [Evidence-based psychotherapy: addiction and personality disorders as comorbidities].

Authors:  T Kienast; E Roediger; M Kensche; J Foerster; I Daig; A Heinz
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

3.  A study of comorbidity in psychoactive substance dependence patients.

Authors:  P Kisore; N Lal; J K Trivedi; P K Dalal; V M Aga
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

Review 4.  Update on the clinical use of buprenorphine: in opioid-related disorders.

Authors:  Simon Ducharme; Ronald Fraser; Kathryn Gill
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

5.  Association of personality disorders with Type A and Type B alcoholics.

Authors:  Miriam Bottlender; Ulrich W Preuss; Michael Soyka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-07-27       Impact factor: 5.270

6.  Premorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?

Authors:  Neslihan Altunsoy; Şafak Yalçın Şahiner; Merve Cingi Külük; Tuncer Okay; Semra Ulusoy Kaymak; Çiğdem Aydemir; Erol Göka
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

7.  A behavioral treatment for opioid-dependent patients with antisocial personality.

Authors:  Karin J Neufeld; Michael S Kidorf; Kenneth Kolodner; Van L King; Michael Clark; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-06-15

8.  Extending the construct validity of dependency among conjugally bereaved adults.

Authors:  Christy A Denckla; Robert F Bornstein; Anthony D Mancini; George A Bonanno
Journal:  Assessment       Date:  2014-07-18

9.  Diagnostic profiles of offenders in substance abuse treatment programs.

Authors:  Christine E Grella; Lisa Greenwell; Michael Prendergast; Stanley Sacks; Gerald Melnick
Journal:  Behav Sci Law       Date:  2008

10.  Dialectical behavior therapy for substance abusers.

Authors:  Linda A Dimeff; Marsha M Linehan
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.